Inventor
POIRIER MARC
US27 patents
⚠️ This page may combine multiple inventors who share the name “POIRIER MARC”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
11 patentsUS5760232AJun 2, 1998
Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
SCHERING CORP45 citations92
US7605275B2Oct 20, 2009
Exo- and diastereo- selective syntheses of himbacine analogs
SCHERING CORP12 citations82
US5998620ADec 7, 1999
Synthesis of intermediates useful in preparing tricyclic compounds
SCHERING CORP13 citations73
US6372909B1Apr 16, 2002
Synthesis of intermediates useful in preparing tricyclic compounds
SCHERING CORP6 citations70
US7528263B2May 5, 2009
Oxidation process for the preparation of N-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-{N-[(tert-butylamino)carbonyl]-3-methyl-L-valyl}-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide and related compounds
SCHERING CORP6 citations59
US7582763B2Sep 1, 2009
Enantioselective process
SCHERING CORP0 citations51
US6750347B2Jun 15, 2004
Synthesis of intermediates useful in preparing tricyclic compounds
SCHERING CORP0 citations51
US6492519B2Dec 10, 2002
Synthesis of intermediates useful in preparing tricyclic compounds
SCHERING CORP1 citations51
US7049440B2May 23, 2006
Enantioselective process
SCHERING CORP1 citations50
US7989653B2Aug 2, 2011
Exo- and diastereo-selective syntheses of himbacine analogs
SCHERING CORP0 citations49
US6495689B2Dec 17, 2002
Synthesis of intermediates useful in preparing tricyclic compounds
SCHERING CORP0 citations48
MERCK SHARP & DOHME
3 patentsUS9688654B2Jun 27, 2017
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations51
US9416126B2Aug 16, 2016
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME2 citations51
US9440952B2Sep 13, 2016
Compounds inhibiting leucine-rich repeat kinase enzyme activity
MERCK SHARP & DOHME1 citations48
PACIFIC REGENERATION TECHNOLOG
2 patentsOPKO HEALTH INC
2 patentsUS9249144B2Feb 2, 2016
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
OPKO HEALTH INC1 citations57
US9822116B2Nov 21, 2017
Process and intermediates for the synthesis of 8-[{1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxy}-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
OPKO HEALTH INC0 citations47